Atorvastatin Impurity 54(CAS: 459-57-4)

CAS Number
Related Products
3-Fluorobenzyl Chloride
CAS Number: 456-42-8
4-Chloro-2-fluoro-1-methylbenzene
CAS Number: 452-75-5
1-Fluoro-3-(trichloromethyl)benzene
CAS Number: 401-77-4
Potassium chloride
CAS Number: 7447-40-7
Potassium hydrogen carbonate
CAS Number: 298-14-6
1-(Chloromethyl)-2-fluorobenzene
CAS Number: 345-35-7
Other Suppliers for Atorvastatin Impurity 54
Basic Information
Molecular Formula
C7H5FO
Molecular Weight
124.11 g/mol
Physical Properties
Melting Point
−10 °C (lit.)
Boiling Point
181 °C/758 mmHg(lit.)
Chemical Identifiers
SMILES
C1=CC(=CC=C1C=O)F
InChIKey
UOQXIWFBQSVDPP-UHFFFAOYSA-N
Database References
MDL Number
MFCD00003378
Beilstein Registry Number
385857
FAQ
Atorvastatin Impurity 54 (CAS: 459-57-4) is a byproduct or contaminant associated with the synthesis of atorvastatin, a cholesterol-lowering medication. It is typically identified during pharmaceutical quality control processes. Its chemical structure is closely related to atorvastatin but may differ slightly in functional groups. The compound is used for impurity analysis and ensuring drug purity in manufacturing.
Atorvastatin Impurity 54 (CAS: 459-57-4) is primarily used in pharmaceutical research and development to identify and quantify impurities in atorvastatin formulations. It also plays a role in drug stability studies and regulatory compliance testing. Additionally, it may be used as a reference standard in analytical methods to ensure the accuracy of quality assurance processes.
Atorvastatin Impurity 54 (CAS: 459-57-4) is not intended for human use and is classified as a controlled substance in pharmaceutical manufacturing. Safety precautions include handling in a well-ventilated area and using appropriate PPE to minimize exposure. It should be managed according to standard laboratory safety protocols to ensure compliance with regulatory guidelines.
Atorvastatin Impurity 54 (CAS: 459-57-4) should be stored in a cool, dry place (2-8°C), protected from light, and in a sealed container to prevent moisture absorption. Proper storage ensures stability and minimizes degradation risks. It is recommended to maintain controlled environmental conditions and follow recommended storage guidelines for pharmaceutical impurities.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Liu Zicheng
Telephone
86-571-64156010 64156120
Fax
86-571-64156812
Visit Website
https://www.dyhg.com








